Public, private investors must fill the void left by venture capitalists

01/10/2013 | Xconomy

Venture capitalists have proven more willing to invest in health care-related software applications than in early-stage medical research, which carries more risk and longer times to return on investment, writes consultant Stewart Lyman. Alliances between Big Pharma and academic institutions, patient group investment units, public funding for research, tax breaks and prizes help encourage research. "Fighting disease isn’t just a good investment in our health; it’s also an excellent investment in our economy," Lyman writes.

View Full Article in:

Xconomy

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director of Product Planning Development; Market Planning, Innovation
Blue Cross Blue Shield of Massachusetts
Quincy , MA
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX